Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2014 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Triferic(TM) Iron Replacement Clinical Data to be Presented at 14th Asian Pacific Congress of Nephrology May 14-17, 2014 in Tokyo, Japan

WIXOM, Mich., April 29, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
April 14, 2014 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Triferic(TM) Iron Replacement Clinical Data Selected for Three Abstract Presentations at National Kidney Foundation Spring Clinical Meetings April 22-26, 2014 in Las Vegas, NV

WIXOM, Mich., April 14, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
March 24, 2014 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Submits New Drug Application for Triferic(TM) for the Treatment of Iron Replacement in Chronic Kidney Disease Patients on Hemodialysis

WIXOM, Mich., March 24, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
March 05, 2014 11:47 ET | Source: Rockwell Medical, Inc.

Rockwell Medical to Host Investor Meeting With Nephrology Key Opinion Leader on March 6, 2014 in New York City

WIXOM, Mich., March 5, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
February 26, 2014 16:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Reports Fourth Quarter 2013 Results

WIXOM, Mich., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
November 05, 2013 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Reports Third Quarter 2013 Results

– Successful Triferic™ Phase 3 Clinical Results Highlight Quarter – - Conference Call 4:15pm Eastern Time - WIXOM, Mich., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical,...
August 01, 2013 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Reports Second Quarter 2013 Results

- Successful Top Line Data from Phase 3 SFP Study Highlight Quarter - - Conference Call at 4:15pm Eastern Time - WIXOM, Mich., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc....
May 15, 2013 07:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Prices $35.0 Million Public Offering of Common Stock

WIXOM, Mich., May 15, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
May 14, 2013 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Proposed Public Offering of Common Stock

WIXOM, Mich., May 14, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
May 08, 2013 16:15 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Long-Term, National Supply Agreement With DaVita

WIXOM, Mich., May 8, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal...